Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Peter Fecci to Neoplasm Recurrence, Local

This is a "connection" page, showing publications Peter Fecci has written about Neoplasm Recurrence, Local.

 
Connection Strength
 
 
 
0.601
 
  1. Chiang VL, Pugazenthi S, Leidig WA, Rodriguez A, Prabhu S, Haskell-Mendoza AP, Fecci PE, Placantonakis DG, Abram SR, Lega B, Kim AH. Laser interstitial thermal therapy for new and recurrent meningioma: a prospective and retrospective case series. J Neurosurg. 2024 09 01; 141(3):642-652.
    View in: PubMed
    Score: 0.128
  2. Schwalb AM, Srinivasan ES, Fecci PE. Commentary: Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort. Neurosurgery. 2022 12 01; 91(6):e160-e163.
    View in: PubMed
    Score: 0.116
  3. Sankey EW, Grabowski MM, Srinivasan ES, Griffin AS, Howell EP, Otvos B, Tsvankin V, Barnett GH, Mohammadi AM, Fecci PE. Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis. Neurosurgery. 2022 06 01; 90(6):684-690.
    View in: PubMed
    Score: 0.112
  4. Peña Pino I, Ma J, Hori YS, Fomchenko E, Dusenbery K, Reynolds M, Wilke C, Yuan J, Srinivasan E, Grabowski M, Fecci P, Domingo-Musibay E, Fujioka N, Barnett GH, Chang V, Mohammadi AM, Chen CC. Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience. J Neurooncol. 2022 Jan; 156(2):295-306.
    View in: PubMed
    Score: 0.110
  5. Zhao J, Vaios E, Calabrese E, Yang Z, Ginn J, Gonzalez A, Floyd S, Reitman ZJ, Fecci P, Kirkpatrick J, Lafata KJ, Wang C. An Explainable Deep Model for Risk Scoring and Accurate Radionecrosis Identification Following Brain Metastasis Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys. 2026 06 01; 125(2):649-659.
    View in: PubMed
    Score: 0.036
  6. Flores C, Dunn G, Fecci P, Lim M, Mitchell D, Reardon DA. Is There a Role for Immunotherapy in Central Nervous System Cancers? Hematol Oncol Clin North Am. 2022 02; 36(1):237-252.
    View in: PubMed
    Score: 0.028
  7. Nduom EK, Gephart MH, Chheda MG, Suva ML, Amankulor N, Battiste JD, Campian JL, Dacey RG, Das S, Fecci PE, Hadjipanayis CG, Hoang KB, Jalali A, Orringer D, Patel AJ, Placantonakis D, Rodriguez A, Yang I, Yu JS, Zipfel GJ, Dunn GP, Leuthardt EC, Kim AH. Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators. Neurosurgery. 2021 06 15; 89(1):129-132.
    View in: PubMed
    Score: 0.026
  8. Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. A review of glioblastoma immunotherapy. J Neurooncol. 2021 Jan; 151(1):41-53.
    View in: PubMed
    Score: 0.024
  9. Narloch JL, Farber SH, Sammons S, McSherry F, Herndon JE, Hoang JK, Yin FF, Sampson JH, Fecci PE, Blackwell KL, Kirkpatrick JP, Kim GJ. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis. Neuro Oncol. 2017 Oct 01; 19(10):1391-1397.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)